cancer - search results

Roche is a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.

We spoke to Dr Charles Shepherd about the impact of myalgic encephalomyelitis/chronic fatigue syndrome and why more needs to be done to address gaps in care and research.

A new technique by researchers at Oregon Health & Science University (OHSU) could change the infertility treatment .

Ever thought about giving blood? Around 2.5 million litres of blood are transfused annually in the UK, but do we know about giving blood? Is it safe? What happens when you donate? Are there any risks? Here is all the information you need

A recent study published in The Lancet has revealed statistics regarding obesity, revealing that more than 1 billion individuals worldwide were struggling with obesity in 2022  Obesity rates among adults have more than doubled since 1990 and quadrupled among children aged 5 to 19 years. The struggles of undernutrition and obesity  The...

How do we tackle sepsis? What role do infection prevention and control play? What are the symptoms? How do we treat sepsis and reduce its risk? Let’s discover more about sepsis here.

InsideOutBio is focused on the immunotherapy of cancers, exploiting newly discovered pathways to overcome tumor-induced suppression of host immune responses.

In this exclusive interview, Dr. Carol Elias simplifies the complex link between metabolism and reproduction, sharing insights into the science behind our physiological balance.

Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.

Stephen Vanner, president of pHarm Therapeutics Inc., and Christoph Stein, inventor and co-founder, discuss a new class of analgesics for pain caused by tissue injury and inflammation.

With the help of artificial intelligence, healthcare professionals can predict patient prognosis.

Linda Morris Brown, MPH, DrPH, FACE, is an internationally recognized epidemiologist with more than 40 years' experience in the design and analysis of epidemiologic data for large-scale, multisite epidemiologic studies in the United States and internationally that involve human health issues Presently, Dr. Brown is Principal Investigator (PI) for the...

Flipons are the next step in DNA research. What they are, their role in DNA and RNA coding, their impact on medical science, and their relation to the immune system are discussed here.

Karen Lee Morrissette and Jean C. Pfau from the Center for Asbestos-Related Disease discuss the clinical presentation and complexity of the autoimmune disease progression among those exposed to Libby Amphibole.

Cristina Oliva is a researcher at the Institute of Leadership and Management in Health at Kingston University She has been a practising oncologist for over 12 years at several national cancer institutes, treating a wide variety of oncology diseases. During her experience in clinical research, she has contributed to the...

Professor Giampiero Favato is the Director of the Institute of Leadership and Management in Health at Kingston University He is also a Fellow of the Royal Society of Public Health, the Royal Society of Medicine, and the European Cancer Organisation. Professor Favato’s research has played an important role in public health...

It may surprise you to know that 60% of women over the age of 65 have high blood pressure. So why are postmenopausal women more at risk of high blood pressure? Let's find out.

Researchers have shed new light on the prevalence of rickets in children during the Industrial Revolution.

UK health research funding reached £5 billion in 2022, but is now plateauing, according to the UK Health Research Analysis 2022. The report, commissioned by the UK Clinical Research Collaboration (UKCRC), provides the most detailed overview yet of UK health research funding from 2004 to 2022 from all public sectors.

Scientists at the University of Virginia have used the power of machine learning to identify potential drugs that could significantly reduce harmful scarring following a heart attack or other injuries.